Cardiff Oncology, Inc.
CRDF· Nasdaq
CRDFCardiff Oncology, Inc.
Filed Mar 12, 2015 · 10-K · 71 days after period end · 0001104659-15-019213
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Revenue | $56.00K | $47.00K | $163.00K | $33.75K |
| Net Income | -$4.68M | -$1.03M | -$6.33M | -$1.25M |
| EPS Diluted | -$0.25 | -$0.05 | -$0.43 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cardiff Oncology, Inc. · CIK 1213037 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Mar 12, 2015 · 71 d after period end
